E ora viaggi, ridi, vivi o sei perduta.
Firenze, Toscana
Joined April 2018
- Tweets214
- Following233
- Followers110
- Likes1.7K
Pinned Tweet
Resistere è il più grande spettacolo dopo il Big Bang. A lezione da @esterviola – at Florence, Tuscany
Francesca Becherucci retweeted
Now open access in @NDTsocial
Eculizumab for RPGN in children
🧐"All pts with longitudinal follow-up achieved a favorable kidney outcome, contrasting the unsatisfactory prognosis reported in pediatric RPGN"
▶️academic.oup.com/ndt/article…
Francesca Becherucci retweeted
Now online in @NDTsocial
Early identification of CKD in pts with a solitary functioning kidney
🧐There is a need for long-term follow-up protocols in congenital single kidney pts from pediatric to adult nephrology care
▶️academic.oup.com/ndt/article…
Our new paper on #CKD in #solitarykidney is out in @NDTsocial. SFK is not a benign condition— patients require longlife follow up starting from childhood
Special thanks to @cirluigi
track.smtpsendmail.com/90321…
Thinking about a genetic disease is often a good idea, even in adults. Ordering genetic testing is essential, but make sure to consult a center with adequate expertise.
Clinical and pathological confirmation of the diagnosis for CKD has limitations, with up to 1/3 of individuals remaining without a formal diagnosis. This study shows that genetic testing is informative in a high proportion of clinically selected adults.
bit.ly/CJASN0564
ALT Visual abstract for "Utility of Genetic Testing in Adults with Chronic Kidney Disease: A Systematic Review and Meta-Analysis."
Francesca Becherucci retweeted
Proud to share our paper in @Kidney_Int! Excited to see our research on anti-slit antibodies in steroid-resistant nephrotic syndrome published—a significant step toward targeted treatments. Huge thanks to my mentor @PRomagnani and @AngelottiLucia.
kidney-international.org/art…
Francesca Becherucci retweeted
Happy to see this finally out. The first study able to define the sensitivity and specificity of commercial anti-nephrin Ab by using kidney biopsies as gold standard. Standard Elisas do the job well. kidney-international.org/art…
Francesca Becherucci retweeted
Look how much more important is to know if a patient is genetic or has anti-slit antibodies than if has MCD or FSGS at kidney biopsy.
We have finally come to the era of autoimmune, genetic and adaptive podocytopathies. No more MCD or FSGS used as diagnosis!
Francesca Becherucci retweeted
Anti-slit antibodies define response to therapy and prognosis much better than histopathological lesion patterns even among patients with steroid-resistant nephrotic syndrome kidney-international.org/act…
Thrilled to share our latest in @Kidney_Int Identifying anti-slit diaphragm antibodies is a game changer for patients with steroid-resistant nephrotic syndrome. Together with genetics, we can finally tailor treatments and improve outcomes.
kidney-international.org/art…
Now online in @NDTsocial
Global epidemiology of kidney cancer
@FrancescaBeche @cirluigi
academic.oup.com/ndt/advance…
Francesca Becherucci retweeted
#NIPTtest (test DNA fetale), gratuito in Valle d’Aosta per le donne in gravidanza.
Considerato un valido mezzo di screening, non è stato inserito nei LEA che entreranno in vigore dal 1 aprile 2024. In tutte le altre regioni è a carico delle famiglie.
osservatoriomalattierare.it/…
La medicina sta andando da un’altra parte, ignorarlo è criminale
L’onere dei costi per le famiglie con #malattierare sarà altissimo.
Dal 1° gennaio 2024 entrerà in vigore un nuovo nomenclatore che escluderà molte analisi genetiche.
📢 L'appello della @SIGU_97.
osservatoriomalattierare.it/…
Our editorial on #exome first strategies in medicine is out in @NDTsocial
Time to change perspective
@cirluigi @fondazionemeyer @UNI_FIRENZE
Now free online in @NDTsocial
Evolving role of first-tier exome sequencing in medical diagnostics academic.oup.com/ndt/article…
Finally out! Proud to be part of the PREDICT team!
In a trial involving infants with grade III, IV, or V vesicoureteral reflux and no previous UTI, continuous antibiotic prophylaxis for 2 years provided a small but significant benefit in preventing a first UTI. Full results of the PREDICT trial: nej.md/45JMma3
Francesca Becherucci retweeted
With CRISPR-Cas9, a repressor of fetal hemoglobin expression was disrupted in hematopoietic stem cells from three persons with sickle cell disease. Edited cells were reinfused. Hematopoiesis was restored. Read the full study results: nej.md/3L64brp
Interesting paper. May the key be the clinical interpretation of results instead of the type of test?
How can labs reduce the number of VUS reported in genetic testing? Exome and genome sequencing have lower VUS numbers compared to multi-gene panel tests. @HeidiRehm bit.ly/47LdM0K
Francesca Becherucci retweeted
Why we need a genomics-savvy healthcare (and public health) workforce. Via @NatureMedicine nature.com/articles/s41591-0…
Francesca Becherucci retweeted
Now in @JASN_News. Finerenone Added to RAS/SGLT2 Blockade for Chronic Kidney Disease in Alport Syndrome. Results of a Randomized Contr… pubmed.ncbi.nlm.nih.gov/3742…
Francesca Becherucci retweeted
A Clinical Workflow for Cost-Saving High-Rate Diagnosis of Genetic Kidney Diseases ow.ly/ZWS250OWSzb @JASN_News
Our new work on Clostridium Septicum superinfection complicating #HUS just released in @JournalofNeph: rare among rare.
@cirluigi @UNI_FIRENZE @fondazionemeyer
link.springer.com/article/10…